Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.

× No keyword cloud information.

14 in total

1. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.

Authors: Ritu Valiyil; Livia Casciola-Rosen; Grace Hong; Andrew Mammen; Lisa Christopher-Stine
Journal: Arthritis Care Res (Hoboken) Date: 2010-09 Impact factor: 4.794

Review 2. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors: Pari Basharat; Lisa Christopher-Stine
Journal: Curr Rheumatol Rep Date: 2015-12 Impact factor: 4.592

3. Novel approaches in the treatment of myositis and myopathies.

Authors: Jemima Albayda; Lisa Christopher-Stine
Journal: Ther Adv Musculoskelet Dis Date: 2012-10 Impact factor: 5.346

Review 4. Cutting edge issues in polymyositis.

Authors: Anna Ghirardello; Sandra Zampieri; Elena Tarricone; Luca Iaccarino; Luisa Gorza; Andrea Doria
Journal: Clin Rev Allergy Immunol Date: 2011-10 Impact factor: 8.667

Review 5. Efficacy and safety of rituximab in rheumatic diseases.

Authors: Eva Rath; Jochen Zwerina; Bastian Oppl; Valerie Nell-Duxneuner
Journal: Wien Med Wochenschr Date: 2015-01-21

Review 6. Therapeutic approaches in myositis.

Authors: Rohit Aggarwal; Chester V Oddis
Journal: Curr Rheumatol Rep Date: 2011-06 Impact factor: 4.686

7. Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.

Authors: Marisa Fernandes das Neves; Joana Caetano; Susana Oliveira; José Delgado Alves
Journal: BMJ Case Rep Date: 2015-08-03

Review 8. Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.

Authors: Linda Nalotto; Luca Iaccarino; Margherita Zen; Mariele Gatto; Elisabetta Borella; Marta Domenighetti; Leonardo Punzi; Andrea Doria
Journal: Immunol Res Date: 2013-07 Impact factor: 2.829

Review 9. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Authors: Merrilee Needham; Frank L Mastaglia
Journal: Neurotherapeutics Date: 2016-01 Impact factor: 7.620

Review 10. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.

Authors: Anji Xiong; Guancui Yang; Zhuoyao Song; Chen Xiong; Deng Liu; Yu Shuai; Linqian He; Liangwen Zhang; Zepeng Guo; Shiquan Shuai
Journal: Ther Adv Neurol Disord Date: 2021-03-12 Impact factor: 6.570